UnitedHealth Group Incorporated $UNH Shares Sold by My Legacy Advisors LLC

Key Points

• My Legacy Advisors LLC reduced its holdings in UnitedHealth Group by 26.2%, owning 3,474 shares valued at $1,040,000 after selling 1,232 shares in the second quarter.
• UnitedHealth Group reported quarterly earnings of $4.08 EPS, missing analysts' expectations of $4.45, with revenue of $111.62 billion.
• The company announced a quarterly dividend of $2.21 per share, resulting in an annualized dividend of $8.84 and a yield of 2.6%.

My Legacy Advisors LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 26.2% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,474 shares of the healthcare conglomerate's stock after selling 1,232 shares during the quarter. My Legacy Advisors LLC's holdings in UnitedHealth Group were worth $1,040,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. GAMMA Investing LLC boosted its stake in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock worth $4,257,131,000 after buying an additional 196,696 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in UnitedHealth Group in the 1st quarter worth about $3,846,764,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $336.72 on Friday. The company has a market cap of $304.96 billion, a P/E ratio of 14.59, a PEG ratio of 2.19 and a beta of 0.45. The stock has a fifty day moving average price of $295.67 and a 200 day moving average price of $365.19. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UNH. Barclays lifted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Morgan Stanley lifted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research note on Friday, September 12th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. JPMorgan Chase & Co. reduced their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. Finally, Truist Financial boosted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research report on Tuesday, September 9th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.